Clomiphene Citrate Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 25 mg, 50 mg, 100 mg
Reference Brands: Clomid® (US & EU), Serophene® (US), Omifin®(EU)
Category:
Women's Health
Clomiphene Citrate oral tablets are widely used for ovulation induction and infertility treatment in women, especially with PCOS. Available in 25 mg, 50 mg, and 100 mg strengths, top brands like Clomid®, Serophene®, and Omifin® are approved in the US and EU. These FDA/EMA-approved tablets are ideal for B2B supply to fertility clinics, hospitals, and pharmacies.
Clomiphene Citrate is available in Tablet
and strengths such as 25 mg, 50 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clomiphene Citrate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clomiphene Citrate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clomiphene Citrate oral tablets are a trusted first-line treatment for ovulatory dysfunction and infertility in women, especially those with PCOS. Widely used across the US and EU, brands like Clomid®, Serophene®, and Omifin® offer strengths of 25 mg to 100 mg. As a selective estrogen receptor modulator (SERM), clomiphene stimulates ovulation with high efficacy and minimal side effects. Available in blister packs and bulk formats, it is distributed to fertility clinics, hospitals, and pharmacies. Approved by FDA and EMA, clomiphene citrate tablets are an essential addition to B2B women's health portfolios in regulated global markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing